Focal adhesion kinase regulates expression of thioredoxin-interacting protein (TXNIP) in cancer cells

Baotran Ho, Grace Huang, Vita M Golubovskaya1

  • 1Department of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263, USA. Vita.Golubovskaya@roswellpark.org.

Insights

This study reveals that Focal Adhesion Kinase (FAK) regulates thioredoxin-interacting protein (TXNIP) expression. Inhibiting FAK in cancer cells increases TXNIP, impacting cell survival and apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Focal Adhesion Kinase (FAK) is crucial for cancer cell survival.
  • Previous studies indicated an inverse relationship between FAK and thioredoxin-interacting protein (TXNIP) expression.
  • Understanding this interaction is key to developing new cancer therapies.

Purpose of the Study:

  • To elucidate the regulatory relationship between FAK and TXNIP.
  • To investigate the functional consequences of FAK-TXNIP interaction in cancer cells.
  • To explore potential therapeutic strategies targeting the FAK-TXNIP axis.

Main Methods:

  • Gene expression profiling (microarray).
  • Overexpression and silencing of FAK using siRNA and doxycycline-induced systems.
  • Reporter assays to assess promoter activity.
  • Treatment with 1alpha, 25-dihydroxyvitamin D3 (1,25D), 5-fluorouracil (5-FU), and FAK inhibitor Y15.
  • Cell viability and apoptosis assays.

Main Results:

  • Overexpression of FAK repressed TXNIP promoter activity in MCF-7 cells.
  • 1,25D and 5-FU treatments modulated FAK and TXNIP protein levels.
  • FAK silencing increased TXNIP protein expression, while FAK overexpression inhibited it in 293 cells.
  • FAK inhibition in glioblastoma cells increased TXNIP mRNA, reduced cell viability, and enhanced apoptosis.

Conclusions:

  • FAK directly regulates TXNIP expression.
  • The FAK-TXNIP axis plays a significant role in cancer cell apoptosis, survival, and oxidative stress signaling.
  • Targeting FAK could be a viable strategy for cancer treatment by modulating TXNIP.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...